Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

TIES Secures $1.5M in Seed Funding to Build Men’s Preconception Health Platform

TIES just raised $1.5M in Seed funding, led by HumanCo and Jason H. Karp, and it lands at a moment when men’s health is long on noise but short on accountability, especially when the conversation turns to fertility. Built in Austin by Camryn Novak, Co-Founder & CEO, and Luke Novak, Co-Founder, TIES starts earlier than most brands are willing to go, not at the moment of need, not when stress is already high, but at the moment responsibility quietly shows up and taps you on the shoulder, asking what you are doing before fatherhood begins.

That question turned into Foundations, the company’s first product, a once-daily men’s fertility and performance supplement formulated with 8 clinically studied ingredients, developed alongside physicians and specialists across reproductive medicine, integrative health, and preconception nutrition, bringing clean inputs, real science, and no mystery math behind the label. Now zoom out, because men contribute to 50% of every fertility journey, yet the system has been built like they are optional participants until proven otherwise, leaving a gap wide enough for an entire category to slip through unnoticed, underbuilt, and underserved, and TIES is stepping directly into that gap with intention.

HumanCo leading this round is not accidental, and Jason H. Karp joining the board is not symbolic, it is a signal that men’s preconception health is being taken seriously as a consumer health vertical, not a side shelf next to generic supplements pretending to do everything for everyone, and the details reinforce that signal, with Foundations manufactured in an FDA-registered, cGMP-compliant facility and supported by third-party testing, which is not marketing language but infrastructure for trust, because in this category trust is the currency before anything else moves.

For Camryn Novak and Luke Novak, this is not theory, it is lived experience, built from navigating preconception themselves, watching the imbalance play out in real time, and deciding not to accept it as the default setting, so they built something that pulls men into the equation earlier with clarity instead of confusion, and there is a business lesson sitting right under the surface, because the strongest companies are not always the loudest, they are the ones that notice what everyone else has normalized, question it, and then build with enough precision that the market starts to rethink its own assumptions, which is exactly where TIES is starting to make noise without needing to shout.